FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008882832> ?p ?o ?g. }

• W3008882832 endingPage "1386" @default.
• W3008882832 startingPage "1386" @default.
• W3008882832 abstract "Circulating microRNA (ct-miRNAs) are able to identify patients with differential response to HER2-targeted therapy. However, their dynamics are largely unknown. We assessed 752 miRNAs from 52 NeoALTTO patients with plasma pairs prior and two weeks after trastuzumab. Increased levels of ct-miR-148a-3p and ct-miR-374a-5p were significantly associated with pathological complete response (pCR) (p = 0.008 and 0.048, respectively). At a threshold ≥ the upper limit of the 95%CI of the mean difference, pCR resulted 45% (95%CI 24%–68%), and 44% (95%CI 22%–69%) for ct-miR-148a-3p and ct-miR-374a-5p, respectively. Notably, ct-miR-148a-3p retained its predictive value (OR 3.42, 95%CI 1.23–9.46, p = 0.018) in bivariate analysis along with estrogen receptor status. Combined information from ct-miR-148a-3p and ct-miR140-5p, which we previously reported to identify trastuzumab-responsive patients, resulted in greater predictive capability over each other, with pCR of 54% (95%CI 25%–81%) and 0% (95%CI 0%–31%) in ct-miR-148a/ct-miR-140-5p high/present and low/absent, respectively. GO and KEGG analyses showed common enriched terms between the targets of these ct-miRNAs, including cell metabolism regulation, AMPK and MAPK signaling, and HCC progression. In conclusion, early modulated ct-miR-148-3p may inform on the functional processes underlying treatment response, integrate the information from already available predictive biomarkers, and identify patients likely to respond to single agent trastuzumab-based neoadjuvant therapy." @default.
• W3008882832 created "2020-03-06" @default.
• W3008882832 creator A5001910485 @default.
• W3008882832 creator A5003405177 @default.
• W3008882832 creator A5011012477 @default.
• W3008882832 creator A5011020262 @default.
• W3008882832 creator A5011668568 @default.
• W3008882832 creator A5020982369 @default.
• W3008882832 creator A5021113979 @default.
• W3008882832 creator A5026775250 @default.
• W3008882832 creator A5037340510 @default.
• W3008882832 creator A5046289000 @default.
• W3008882832 creator A5049907389 @default.
• W3008882832 creator A5052679679 @default.
• W3008882832 creator A5060837793 @default.
• W3008882832 creator A5062462121 @default.
• W3008882832 creator A5064488646 @default.
• W3008882832 creator A5067146231 @default.
• W3008882832 creator A5072306573 @default.
• W3008882832 creator A5075251118 @default.
• W3008882832 creator A5075656335 @default.
• W3008882832 creator A5081259888 @default.
• W3008882832 creator A5081663693 @default.
• W3008882832 creator A5087380706 @default.
• W3008882832 date "2020-02-18" @default.
• W3008882832 modified "2023-10-14" @default.
• W3008882832 title "Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy" @default.
• W3008882832 cites W1482814115 @default.
• W3008882832 cites W1962305777 @default.
• W3008882832 cites W1977881314 @default.
• W3008882832 cites W1981966610 @default.
• W3008882832 cites W1987963534 @default.
• W3008882832 cites W2005401913 @default.
• W3008882832 cites W2006070721 @default.
• W3008882832 cites W2014946489 @default.
• W3008882832 cites W2025865695 @default.
• W3008882832 cites W2027441950 @default.
• W3008882832 cites W2059433308 @default.
• W3008882832 cites W2061349734 @default.
• W3008882832 cites W2075894019 @default.
• W3008882832 cites W2085757352 @default.
• W3008882832 cites W2087367550 @default.
• W3008882832 cites W2093089132 @default.
• W3008882832 cites W2104659222 @default.
• W3008882832 cites W2105549148 @default.
• W3008882832 cites W2107277218 @default.
• W3008882832 cites W2107684325 @default.
• W3008882832 cites W2109227959 @default.
• W3008882832 cites W2111578514 @default.
• W3008882832 cites W2124756133 @default.
• W3008882832 cites W2149612004 @default.
• W3008882832 cites W2167587342 @default.
• W3008882832 cites W2192080449 @default.
• W3008882832 cites W2284518511 @default.
• W3008882832 cites W2308771977 @default.
• W3008882832 cites W2464822550 @default.
• W3008882832 cites W2522558734 @default.
• W3008882832 cites W2753109313 @default.
• W3008882832 cites W2804641693 @default.
• W3008882832 cites W2888471542 @default.
• W3008882832 cites W2897825874 @default.
• W3008882832 cites W2899540665 @default.
• W3008882832 cites W2916436075 @default.
• W3008882832 cites W2917102036 @default.
• W3008882832 cites W2917743351 @default.
• W3008882832 cites W2922203908 @default.
• W3008882832 doi "https://doi.org/10.3390/ijms21041386" @default.
• W3008882832 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7073028" @default.
• W3008882832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32085669" @default.
• W3008882832 hasPublicationYear "2020" @default.
• W3008882832 type Work @default.
• W3008882832 sameAs 3008882832 @default.
• W3008882832 citedByCount "26" @default.
• W3008882832 countsByYear W30088828322020 @default.
• W3008882832 countsByYear W30088828322021 @default.
• W3008882832 countsByYear W30088828322022 @default.
• W3008882832 countsByYear W30088828322023 @default.
• W3008882832 crossrefType "journal-article" @default.
• W3008882832 hasAuthorship W3008882832A5001910485 @default.
• W3008882832 hasAuthorship W3008882832A5003405177 @default.
• W3008882832 hasAuthorship W3008882832A5011012477 @default.
• W3008882832 hasAuthorship W3008882832A5011020262 @default.
• W3008882832 hasAuthorship W3008882832A5011668568 @default.
• W3008882832 hasAuthorship W3008882832A5020982369 @default.
• W3008882832 hasAuthorship W3008882832A5021113979 @default.
• W3008882832 hasAuthorship W3008882832A5026775250 @default.
• W3008882832 hasAuthorship W3008882832A5037340510 @default.
• W3008882832 hasAuthorship W3008882832A5046289000 @default.
• W3008882832 hasAuthorship W3008882832A5049907389 @default.
• W3008882832 hasAuthorship W3008882832A5052679679 @default.
• W3008882832 hasAuthorship W3008882832A5060837793 @default.
• W3008882832 hasAuthorship W3008882832A5062462121 @default.
• W3008882832 hasAuthorship W3008882832A5064488646 @default.
• W3008882832 hasAuthorship W3008882832A5067146231 @default.
• W3008882832 hasAuthorship W3008882832A5072306573 @default.
• W3008882832 hasAuthorship W3008882832A5075251118 @default.
• W3008882832 hasAuthorship W3008882832A5075656335 @default.
• W3008882832 hasAuthorship W3008882832A5081259888 @default.

• next